Rebecca Yu is the Vice President, Market Access & External Affairs at Takeda Canada. Prior to assuming this role, she held the position of Head, JLABS Canada and was instrumental in setting up J&J Innovations first JLABS incubator outside the United States. She was previously the Director of Strategic Health Technology Assessment (HTA) at Janssen Canada. Rebecca has over 15 years of pharmaceutical industry experience in a range of positions with Solvay Pharma, Procter & Gamble, Servier & Pfizer, covering external engagement and innovation sourcing, health policy, medical affairs and government affairs, pricing, HTA and reimbursement.
Prior to joining industry, she practiced as a Clinical Pharmacist at The Wellesley Hospital. Rebecca is a graduate of the University of Toronto, Faculty of Pharmacy and is currently a pharmacist in Ontario. Rebecca was previously on the Board of Directors for the Markham Stouffville Hospital and was a member of the Joint Steering Committee. She is currently on the Life Sciences Ontarios Board of Directors.